Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06182163 · ClinicalTrials.gov registry record · NA
Reduce Sedentary Time in Acute Lymphoblastic Leukemia
A NA study of Acute Lymphoblastic Leukemia (ALL), sponsored by Children's Hospital Los Angeles.
- Completed
- Registry status
- NA
- Development phase
- 20
- Enrollment target
- 1
- Study location
NCT06182163 is a NA study of Acute Lymphoblastic Leukemia (ALL) that has completed, run by Children's Hospital Los Angeles. The registered enrollment target is 20 participants, below the 6,305-participant average among 16 other Acute Lymphoblastic Leukemia (ALL) trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06182163, a NA study of Acute Lymphoblastic Leukemia (ALL), has completed, sponsored by Children's Hospital Los Angeles.
- COMPLETED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this feasibility trial is to test if a mobile health intervention, including a wearable fitness tracker with inactivity-triggered reminders to move, individualized coaching sessions, and an app-based peer support group, can decrease sedentary time (time spent sitting/lying down and inactive) in adolescents and young adults (AYAs) with acute lymphoblastic leukemia (ALL) receiving maintenance chemotherapy. The main questions it aims to answer are: * Is the intervention a feasible and acceptable way to decrease sedentary time among adolescents and young adults (AYAs) with ALL? * Does the intervention show evidence that it may decrease sedentary time? * Does the intervention show evidence that it may increase quality of life, reduce inflammation, and improve glucose and lipid metabolism? Participants will use their fitness tracker with reminders to move as well as support from other intervention participants and coaching with study staff to gradually decrease their sedentary time over 10 weeks. Researchers will compare participant pre- and post-intervention study measures to see if the program may be helpful to decrease sedentary time in adolescents and young adults (AYAs) with ALL. All participants will wear an activity tracker on the thigh for 7 days at the beginning and end of the study as well as complete quality of life questionnaires. Study labs will be collected three times (baseline, 8 weeks, and 12 weeks) over the course of the 12-week study. All in-person study visits and labs will occur in conjunction with Oncology clinic visits for maintenance chemotherapy.
Conditions Studied
Interventions
- BEHAVIORAL Sedentary time intervention
Study Locations (1)
California
- Children's Hospital Los Angeles - Los Angeles
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2024-07-01 |
| Est. Completion | 2025-12-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06182163
The ClinicalTrials.gov registry entry for NCT06182163 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 6,305-participant average among 16 other Acute Lymphoblastic Leukemia (ALL) trials with a reported enrollment target (100% lower). The listed sponsor is Children's Hospital Los Angeles, which has 119 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Acute Lymphoblastic Leukemia (ALL) appearing as the primary indexed condition, and to 1 intervention - of which Sedentary time intervention is the first listed.
NCT06182163 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT06182163 about?
NCT06182163 is a clinical study titled "Reduce Sedentary Time in Acute Lymphoblastic Leukemia". The goal of this feasibility trial is to test if a mobile health intervention, including a wearable fitness tracker with inactivity-triggered reminders to move, individualized coaching sessions, and an app-based peer support group, can decrease sedentary time (time spent sitting/lying down and inact...
What is the current status of trial NCT06182163?
This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2024-07-01. Estimated completion is 2025-12-10.
What conditions does trial NCT06182163 study?
This clinical trial studies the following conditions: Acute Lymphoblastic Leukemia (ALL).
What interventions are being tested in trial NCT06182163?
The interventions under investigation include: Sedentary time intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT06182163?
This trial is sponsored by Children's Hospital Los Angeles, which has 119 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06182163 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Acute Lymphoblastic Leukemia (ALL)
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Bright Ideas - CIN Feasibility Study
RECRUITING · NA
-
Transcutaneous Auricular Vagus Nerve Stimulation for Insomnia in Survivors of Childhood Acute Lymphoblastic Leukemia
RECRUITING · NA
-
Bone Marrow and Kidney Transplant for Patients With Chronic Kidney Disease and Blood Disorders
COMPLETED · NA
-
Cord Blood Transplant in Adults With Blood Cancers
RECRUITING · Phase 2
-
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
RECRUITING
-
Multi-virus CTLs Expressing CD19 Chimeric Receptors, CD19 Positive Malignancies Post SCT, MULTIPRAT
ACTIVE NOT RECRUITING · Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.